Stoke Therapeutics, Inc. (STOK)
30.05
+0.24
(+0.81%)
USD |
NASDAQ |
Sep 08, 16:00
29.60
-0.45
(-1.50%)
After-Hours: 07:26
Stoke Therapeutics Market Cap : 1.875B for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.875B |
| September 04, 2026 | 1.860B |
| September 03, 2026 | 1.871B |
| September 02, 2026 | 1.903B |
| September 01, 2026 | 1.928B |
| August 31, 2026 | 1.947B |
| August 28, 2026 | 1.973B |
| August 27, 2026 | 2.034B |
| August 26, 2026 | 2.065B |
| August 25, 2026 | 2.088B |
| August 24, 2026 | 2.017B |
| August 21, 2026 | 2.015B |
| August 20, 2026 | 1.959B |
| August 19, 2026 | 2.061B |
| August 18, 2026 | 2.006B |
| August 17, 2026 | 2.005B |
| August 14, 2026 | 1.951B |
| August 13, 2026 | 1.954B |
| August 12, 2026 | 2.057B |
| August 11, 2026 | 2.057B |
| August 10, 2026 | 2.011B |
| August 07, 2026 | 2.041B |
| August 06, 2026 | 1.993B |
| August 05, 2026 | 1.993B |
| August 04, 2026 | 1.976B |
| Date | Value |
|---|---|
| August 03, 2026 | 1.845B |
| July 31, 2026 | 1.801B |
| July 30, 2026 | 1.875B |
| July 29, 2026 | 1.835B |
| July 28, 2026 | 1.829B |
| July 27, 2026 | 1.824B |
| July 24, 2026 | 1.824B |
| July 23, 2026 | 1.845B |
| July 22, 2026 | 1.802B |
| July 21, 2026 | 1.793B |
| July 20, 2026 | 1.723B |
| July 17, 2026 | 1.808B |
| July 16, 2026 | 1.812B |
| July 15, 2026 | 1.862B |
| July 14, 2026 | 1.813B |
| July 13, 2026 | 1.834B |
| July 10, 2026 | 1.953B |
| July 09, 2026 | 2.043B |
| July 08, 2026 | 2.032B |
| July 07, 2026 | 2.055B |
| July 06, 2026 | 2.018B |
| July 02, 2026 | 2.035B |
| July 01, 2026 | 2.036B |
| June 30, 2026 | 2.037B |
| June 29, 2026 | 2.016B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 31.39B |
| Agenus, Inc. | 316.63M |
| Amgen, Inc. | 212.55B |
| Anika Therapeutics, Inc. | 281.58M |
| BioCryst Pharmaceuticals, Inc. | 2.314B |
Market Cap Related Metrics
| PS Ratio | 67.01 |
| Price to Book Value | 5.427 |
| Price | 30.05 |
| Earnings Yield | -11.22% |